Screener
iRadimed IRMD Gross Profit
Gross Profit at other companies
Other financials
Where this comes from
Calculated from iRadimed’s reported figures.
The source filing: iRadimed’s 10-Q, filed May 1, 2026.
- Filed
- May 1, 2026, 4:08 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-029325
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Revenue | $21,979 | $19,511 |
| Cost of revenue | 5,165 | 4,668 |
| Gross profit | 16,814 | 14,843 |
| Operating expenses: | ||
| General and administrative | 4,569 | 4,611 |
| Sales and marketing | 4,052 | 4,176 |
| Research and development | 956 | 624 |
| Total operating expenses | 9,577 | 9,411 |
Item 1. Condensed Financial Statements
FAQ
- What is iRadimed's gross profit?
- iRadimed (IRMD) reported gross profit of $16.81M in Q1 2026.
- How has iRadimed's gross profit changed year-over-year?
- iRadimed's gross profit increased by 13.3% year-over-year, from $14.84M to $16.81M.
- What is the long-term trend for iRadimed's gross profit?
- Over 4 years (2021 to 2025), iRadimed's gross profit has grown at a 19.0% compound annual growth rate (CAGR), from $32.05M to $64.32M.
- What does gross profit mean?
- Revenue minus cost of revenue — the profit available to cover operating expenses, representing the company's pricing power and production efficiency.
Ask your AI about iRadimed's gross profit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude